| Code | Display | Definition |
| 143 |
Adenovirus types 4 and 7 |
Adenovirus, type 4 and type 7, live, oral |
| 54 |
Adenovirus, type 4 |
Adenovirus vaccine, type 4, live, oral |
| 55 |
Adenovirus, type 7 |
Adenovirus vaccine, type 7, live, oral |
| 82 |
Adenovirus, unspecified formulation |
Adenovirus vaccine, unspecified formulation |
| 181 |
Anthrax immune globulin |
Anthrax immune globulin |
| 319 |
Anthrax vaccine, unspecified |
Anthrax vaccine, unspecified |
| 318 |
Anthrax, post-exposure prophylaxis |
Anthrax vaccine, adsorbed, adjuvanted, post-exposure prophylaxis |
| 24 |
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis |
Anthrax vaccine, adsorbed, pre-exposure and post-exposure prophylaxis |
| 801 |
As03 adjuvant |
As03 adjuvant |
| 19 |
Bcg |
Bacillus calmette-guerin vaccine |
| 27 |
Botulinum antitoxin |
Botulinum antitoxin |
| 317 |
Chikungunya live attenuated vaccine, 0.5 ml, pf |
Chikungunya, live attenuated vaccine, 0.5 ml, preservative free |
| 173 |
Cholera, bivwc |
Cholera, bivwc |
| 174 |
Cholera, live attenuated |
Cholera, live attenuated |
| 26 |
Cholera, unspecified formulation |
Cholera vaccine, unspecified formulation |
| 172 |
Cholera, wc-rbs |
Cholera, wc-rbs |
| 29 |
Cmvig |
Cytomegalovirus immune globulin, intravenous |
| 516 |
Cov-2 covid-19 inactivated non-us vaccine product (minhai biotechnology co, kconvac) |
Sars-cov-2 covid-19 inactivated non-us vaccine product (minhai biotechnology co, kconvac) |
| 518 |
Covid-19 inactivated, non-us vaccine (vla2001, valneva) |
Sars-cov-2 covid-19 inactivated, non-us vaccine (vla2001, valneva) |
| 510 |
Covid-19 iv non-us vaccine (bibp, sinopharm) |
Sars-cov-2 covid-19 inactivated virus non-us vaccine product (bibp, sinopharm) |
| 511 |
Covid-19 iv non-us vaccine (coronavac, sinovac) |
Sars-cov-2 covid-19 inactivated virus non-us vaccine product (coronavac, sinovac) |
| 502 |
Covid-19 iv non-us vaccine (covaxin) |
Sars-cov-2 covid-19 inactivated virus non-us vaccine product (covaxin) |
| 501 |
Covid-19 iv non-us vaccine (qazcovid-in) |
Sars-cov-2 covid-19 inactivated virus non-us vaccine product (qazcovid-in) |
| 503 |
Covid-19 lav non-us vaccine (covivac) |
Sars-cov-2 covid-19 live attenuated virus non-us vaccine product (covivac) |
| 519 |
Covid-19 mrna, bivalent, original/omicron ba.1, non-us vaccine (spikevax bivalent), moderna |
Sars-cov-2 covid-19 mrna, bivalent, original/omicron ba.1, non-us vaccine (spikevax bivalent), moderna |
| 520 |
Covid-19 mrna, bivalent, original/omicron ba.1, non-us vaccine product, pfizer-biontech |
Sars-cov-2 covid-19 mrna, bivalent, original/omicron ba.1, non-us vaccine product (comirnaty bivalent), pfizer-biontech |
| 500 |
Covid-19 non-us vaccine, product unknown |
Sars-cov-2 covid-19 non-us vaccine, specific product unknown |
| 507 |
Covid-19 ps non-us vaccine (anhui zhifei longcom biopharm + inst of micro, chinese acad of sciences) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (anhui zhifei longcom biopharmaceutical + institute of microbiology, chinese academy of sciences) |
| 509 |
Covid-19 ps non-us vaccine (epivaccorona) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (epivaccorona) |
| 508 |
Covid-19 ps non-us vaccine (jiangsu province centers for disease control and prevention) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (jiangsu province centers for disease control and prevention) |
| 521 |
Covid-19 sp, protein-based, adjuvanted (vidprevtyn beta), sanofi-gsk |
Sars-cov-2 (covid-19) vaccine sp, protein-based, adjuvanted, b.1.351 strain (vidprevtyn beta), sanofi-gsk |
| 212 |
Covid-19 vaccine, vector-nr, rs-ad26, pf, 0.5 ml |
Sars-cov-2 (covid-19) vaccine, vector non-replicating, recombinant spike protein-ad26, preservative free, 0.5 ml |
| 210 |
Covid-19 vaccine, vector-nr, rs-chadox1, pf, 0.5 ml |
Sars-cov-2 (covid-19) vaccine, vector non-replicating, recombinant spike protein-chadox1, preservative free, 0.5 ml |
| 506 |
Covid-19 vvnr non-us vaccine (cansino biological inc./beijing institute of biotechnology |
Sars-cov-2 covid-19 viral vector non-replicating non-us vaccine product (convidecia), cansino biological inc./beijing institute of biotechnology |
| 504 |
Covid-19 vvnr non-us vaccine (sputnik light) |
Sars-cov-2 covid-19 viral vector non-replicating non-us vaccine product (sputnik light) |
| 505 |
Covid-19 vvnr non-us vaccine (sputnik v) |
Sars-cov-2 covid-19 viral vector non-replicating non-us vaccine product (sputnik v) |
| 226 |
Covid-19, d614, recomb, pres dtm, as03 adjuvant add, pf, 10mcg/0.5ml |
Sars-cov-2 (covid-19) vaccine, d614, prefusion spike recombinant protein subunit (cov2 pres dtm), as03 adjuvant added, preservative free, 10mcg/0.5ml dose |
| 225 |
Covid-19, d614, recomb, pres dtm, as03 adjuvant add, pf, 5mcg/0.5ml |
Sars-cov-2 (covid-19) vaccine, d614, prefusion spike recombinant protein subunit (cov2 pres dtm), as03 adjuvant added, preservative free, 5mcg/0.5ml dose |
| 230 |
Covid-19, mrna, lnp-s, bivalent, pf, 10 mcg/0.2 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, bivalent, preservative free, 10 mcg/0.2 ml dose |
| 301 |
Covid-19, mrna, lnp-s, bivalent, pf, 10 mcg/0.2 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, bivalent, preservative free, 10 mcg/0.2 ml dose, tris-sucrose formulation |
| 302 |
Covid-19, mrna, lnp-s, bivalent, pf, 3 mcg/0.2 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, bivalent, preservative free, 3 mcg/0.2 ml dose, tris-sucrose formulation |
| 300 |
Covid-19, mrna, lnp-s, bivalent, pf, 30 mcg/0.3 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, bivalent, preservative free, 30 mcg/0.3 ml dose, tris-sucrose formulation |
| 229 |
Covid-19, mrna, lnp-s, bivalent, pf, 50 mcg/0.5 ml or 25mcg/0.25 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, bivalent, preservative free, 50 mcg/0.5 ml or 25 mcg/0.25 ml dose |
| 218 |
Covid-19, mrna, lnp-s, pf, 10 mcg/0.2 ml dose, tris-sucrose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 10 mcg/0.2ml dose, tris-sucrose formulation |
| 207 |
Covid-19, mrna, lnp-s, pf, 100 mcg/0.5ml dose or 50 mcg/0.25ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 100 mcg/0.5ml dose or 50 mcg/0.25ml dose |
| 311 |
Covid-19, mrna, lnp-s, pf, 25 mcg/0.25 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 25 mcg/0.25 ml dose |
| 219 |
Covid-19, mrna, lnp-s, pf, 3 mcg/0.2 ml dose, tris-sucrose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 3 mcg/0.2ml dose, tris-sucrose formulation |
| 208 |
Covid-19, mrna, lnp-s, pf, 30 mcg/0.3 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 30 mcg/0.3ml dose |
| 217 |
Covid-19, mrna, lnp-s, pf, 30 mcg/0.3 ml dose, tris-sucrose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 30 mcg/0.3ml dose, tris-sucrose formulation |
| 312 |
Covid-19, mrna, lnp-s, pf, 50 mcg/0.5 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 50 mcg/0.5 ml dose |
| 221 |
Covid-19, mrna, lnp-s, pf, 50 mcg/0.5 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, 50 mcg/0.5 ml dose |
| 228 |
Covid-19, mrna, lnp-s, pf, pediatric 25 mcg/0.25 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, pediatric 25 mcg/0.25 ml dose |
| 227 |
Covid-19, mrna, lnp-s, pf, pediatric 50 mcg/0.5 ml dose |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, pediatric 50 mcg/0.5 ml dose |
| 310 |
Covid-19, mrna, lnp-s, pf, tris-sucrose, 10 mcg/0.3 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, tris-sucrose, 10 mcg/0.3 ml dose |
| 308 |
Covid-19, mrna, lnp-s, pf, tris-sucrose, 3 mcg/0.3 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, tris-sucrose, 3 mcg/0.3 ml dose |
| 309 |
Covid-19, mrna, lnp-s, pf, tris-sucrose, 30 mcg/0.3 ml |
Sars-cov-2 (covid-19) vaccine, mrna, spike protein, lnp, preservative free, tris-sucrose, 30 mcg/0.3 ml dose |
| 313 |
Covid-19, subunit, rs-nanoparticle, adjuvanted, pf, 5 mcg/0.5 ml |
Sars-cov-2 (covid-19) vaccine, subunit, recombinant spike protein-nanoparticle+matrix-m1 adjuvant, preservative free, 5 mcg/0.5 ml dose |
| 211 |
Covid-19, subunit, rs-nanoparticle+matrix-m1 adjuvant, pf, 0.5 ml |
Sars-cov-2 (covid-19) vaccine, subunit, recombinant spike protein-nanoparticle+matrix-m1 adjuvant, preservative free, 0.5ml dose |
| 56 |
Dengue fever tetravalent |
Dengue fever vaccine, tetravalent |
| 12 |
Diphtheria antitoxin |
Diphtheria antitoxin |
| 28 |
Dt (pediatric) |
Diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 195 |
Dt, ipv adsorbed |
Diphtheria, tetanus, poliomyelitis adsorbed |
| 20 |
Dtap |
Diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 106 |
Dtap, 5 pertussis antigens |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 |
Dtap, unspecified formulation |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
| 146 |
Dtap,ipv,hib,hepb |
Diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, haemophilus b conjugate (meningococcal protein conjugate), and hepatitis b (recombinant) vaccine. |
| 170 |
Dtap/ipv/hib - non-us |
Non-us diphtheria, tetanus toxoids and acellular pertussis vaccine, haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (dtap-hib-ipv) |
| 110 |
Dtap-hep b-ipv |
Dtap-hepatitis b and poliovirus vaccine |
| 50 |
Dtap-hib |
Dtap-haemophilus influenzae type b conjugate vaccine |
| 120 |
Dtap-hib-ipv |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (dtap-hib-ipv) |
| 130 |
Dtap-ipv |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
| 132 |
Dtap-ipv-hib-hep b, historical |
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, haemophilus b conjugate and hepatitis b (recombinant) vaccine. |
| 01 |
Dtp |
Diphtheria, tetanus toxoids and pertussis vaccine |
| 198 |
Dtp-hepb-hib pentavalent non-us |
Diphtheria, pertussis, tetanus, hepatitis b, haemophilus influenza type b, (pentavalent) |
| 22 |
Dtp-hib |
Dtp-haemophilus influenzae type b conjugate vaccine |
| 102 |
Dtp-hib-hep b |
Dtp- haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 204 |
Ebola zaire vaccine, live, recombinant, 1ml dose |
Ebola zaire vaccine, live, recombinant, 1ml dose |
| 214 |
Ebola, unspecified |
Ebola, unspecified |
| 57 |
Hantavirus |
Hantavirus vaccine |
| 30 |
Hbig |
Hepatitis b immune globulin |
| 52 |
Hep a, adult |
Hepatitis a vaccine, adult dosage |
| 154 |
Hep a, ig |
Hepatitis a immune globulin |
| 169 |
Hep a, live attenuated |
Hep a, live attenuated-im |
| 83 |
Hep a, ped/adol, 2 dose |
Hepatitis a vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 |
Hep a, ped/adol, 3 dose |
Hepatitis a vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 31 |
Hep a, pediatric, unspecified formulation |
Hepatitis a vaccine, pediatric dosage, unspecified formulation |
| 85 |
Hep a, unspecified formulation |
Hepatitis a vaccine, unspecified formulation |
| 104 |
Hep a-hep b |
Hepatitis a and hepatitis b vaccine |
| 193 |
Hep a-hep b, pediatric/adolescent |
Hepatitis a and hepatitis b vaccine, pediatric/adolescent (non-us) |
| 08 |
Hep b, adolescent or pediatric |
Hepatitis b vaccine, pediatric or pediatric/adolescent dosage |
| 42 |
Hep b, adolescent/high risk infant |
Hepatitis b vaccine, adolescent/high risk infant dosage |
| 43 |
Hep b, adult |
Hepatitis b vaccine, adult dosage |
| 44 |
Hep b, dialysis |
Hepatitis b vaccine, dialysis patient dosage |
| 45 |
Hep b, unspecified formulation |
Hepatitis b vaccine, unspecified formulation |
| 58 |
Hep c |
Hepatitis c vaccine |
| 59 |
Hep e |
Hepatitis e vaccine |
| 220 |
Hepb recombinant, 3-antigen, al(oh)3 |
Hepatitis b vaccine (recombinant), 3-antigen, al(oh)3 adjuvanted |
| 189 |
Hepb-cpg |
Hepatitis b vaccine (recombinant), cpg adjuvanted |
| 60 |
Herpes simplex 2 |
Herpes simplex virus, type 2 vaccine |
| 47 |
Hib (hboc) |
Haemophilus influenzae type b vaccine, hboc conjugate |
| 46 |
Hib (prp-d) |
Haemophilus influenzae type b vaccine, prp-d conjugate |
| 49 |
Hib (prp-omp) |
Haemophilus influenzae type b vaccine, prp-omp conjugate |
| 48 |
Hib (prp-t) |
Haemophilus influenzae type b vaccine, prp-t conjugate |
| 17 |
Hib, unspecified formulation |
Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 51 |
Hib-hep b |
Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 61 |
Hiv |
Human immunodeficiency virus vaccine |
| 118 |
Hpv, bivalent |
Human papilloma virus vaccine, bivalent |
| 62 |
Hpv, quadrivalent |
Human papilloma virus vaccine, quadrivalent |
| 137 |
Hpv, unspecified formulation |
Hpv, unspecified formulation |
| 165 |
Hpv9 |
Human papillomavirus 9-valent vaccine |
| 86 |
Ig |
Immune globulin, intramuscular |
| 14 |
Ig, unspecified formulation |
Immune globulin, unspecified formulation |
| 87 |
Igiv |
Immune globulin, intravenous |
| 160 |
Influenza a monovalent (h5n1), adjuvanted-2013 |
Influenza a monovalent (h5n1), adjuvanted, national stockpile 2013 |
| 151 |
Influenza nasal, unspecified formulation |
Influenza nasal, unspecified formulation |
| 205 |
Influenza, adjuvanted, quadrivalent, pf |
Influenza, adjuvanted, inactivated, quadrivalent, injectable, preservative free |
| 168 |
Influenza, adjuvanted, trivalent, pf |
Influenza, adjuvanted, inactivated, trivalent, injectable, preservative free |
| 123 |
Influenza, h5n1-1203 |
Influenza virus vaccine, h5n1, a/vietnam/1203/2004 (national stockpile) |
| 197 |
Influenza, high-dose, quadrivalent, pf |
Influenza, high-dose, split virus, quadrivalent, injectable, preservative free |
| 135 |
Influenza, high-dose, trivalent, pf |
Influenza, high-dose, split virus, trivalent, injectable, preservative free |
| 161 |
Influenza, injectable,quadrivalent, preservative free, pediatric |
Influenza, injectable,quadrivalent, preservative free, pediatric |
| 166 |
Influenza, intradermal, quadrivalent, preservative free |
Influenza, intradermal, quadrivalent, preservative free, injectable |
| 149 |
Influenza, live, quadrivalent, intranasal |
Influenza, live, quadrivalent, intranasal |
| 111 |
Influenza, live, trivalent, intranasal |
Influenza, live, trivalent, intranasal |
| 171 |
Influenza, mdck, quadrivalent, pf |
Influenza, madin darby canine kidney, subunit, quadrivalent, injectable, preservative free |
| 186 |
Influenza, mdck, quadrivalent, preservative |
Influenza, madin darby canine kidney, subunit, quadrivalent, injectable, contains preservative |
| 153 |
Influenza, mdck, trivalent, pf |
Influenza, madin darby canine kidney, subunit, trivalent, injectable, preservative free |
| 320 |
Influenza, mdck, trivalent, preservative |
Influenza, madin darby canine kidney, subunit, trivalent, injectable, contains preservative |
| 185 |
Influenza, recombinant, quadrivalent, pf |
Influenza, recombinant, quadrivalent, injectable, preservative free |
| 155 |
Influenza, recombinant, trivalent, pf |
Influenza, recombinant, trivalent, injectable, preservative free |
| 144 |
Influenza, seasonal, intradermal, preservative free |
Seasonal influenza, intradermal, preservative free |
| 194 |
Influenza, southern hemisphere |
Influenza, southern hemisphere, unspecified formulation |
| 231 |
Influenza, southern hemisphere, high-dose, quadrivalent |
Influenza, seasonal, southern hemisphere, high-dose, quadrivalent, 0.7ml dose, preservative free |
| 200 |
Influenza, southern hemisphere, pediatric, preservative free |
Influenza, seasonal, southern hemisphere, quadrivalent, pediatric 0.25ml dose, preservative free |
| 201 |
Influenza, southern hemisphere, preservative free |
Influenza, seasonal, southern hemisphere, quadrivalent, 0.5ml dose, no preservative |
| 202 |
Influenza, southern hemisphere, quadrivalent, with preservative |
Influenza, seasonal, southern hemisphere, quadrivalent, 0.5ml dose, with preservative |
| 15 |
Influenza, split (incl. purified surface antigen) |
Influenza virus vaccine, split virus (incl. purified surface antigen)-retired code |
| 150 |
Influenza, split virus, quadrivalent, pf |
Influenza, split virus, quadrivalent, injectable, preservative free |
| 158 |
Influenza, split virus, quadrivalent, preservative |
Influenza, split virus, quadrivalent, injectable, contains preservative |
| 140 |
Influenza, split virus, trivalent, pf |
Influenza, split virus, trivalent, injectable, preservative free |
| 141 |
Influenza, split virus, trivalent, preservative |
Influenza, split virus, trivalent, injectable, contains preservative |
| 88 |
Influenza, unspecified formulation |
Influenza virus vaccine, unspecified formulation |
| 16 |
Influenza, whole |
Influenza virus vaccine, whole virus |
| 323 |
Influenza-avian, h5, unspecified formulation |
Influenza-avian, h5, unspecified formulation |
| 321 |
Influenza-avian, h5n8, monovalent, pf |
Influenza-avian, h5n8, viral-vector, monovalent, injectable, preservative free |
| 322 |
Influenza-avian, h5n8, monovalent, preservative |
Influenza-avian, h5n8, viral-vector, monovalent, injectable, contains preservative |
| 10 |
Ipv |
Poliovirus vaccine, inactivated |
| 134 |
Japanese encephalitis im |
Japanese encephalitis vaccine for intramuscular administration |
| 39 |
Japanese encephalitis sc |
Japanese encephalitis vaccine sc |
| 129 |
Japanese encephalitis, unspecified formulation |
Japanese encephalitis vaccine, unspecified formulation |
| 63 |
Junin virus |
Junin virus vaccine |
| 64 |
Leishmaniasis |
Leishmaniasis vaccine |
| 65 |
Leprosy |
Leprosy vaccine |
| 66 |
Lyme disease |
Lyme disease vaccine |
| 04 |
M/r |
Measles and rubella virus vaccine |
| 67 |
Malaria |
Malaria vaccine |
| 05 |
Measles |
Measles virus vaccine |
| 68 |
Melanoma |
Melanoma vaccine |
| 191 |
Meningococcal a polysaccharide (non-us) |
Meningococcal a polysaccharide vaccine (non-us) |
| 192 |
Meningococcal ac polysaccharide (non-us) |
Meningococcal ac polysaccharide vaccine (non-us) |
| 108 |
Meningococcal acwy, unspecified formulation |
Meningococcal acwy vaccine, unspecified formulation |
| 163 |
Meningococcal b, omv |
Meningococcal b vaccine, recombinant, omv, adjuvanted |
| 162 |
Meningococcal b, recombinant |
Meningococcal b vaccine, fully recombinant |
| 164 |
Meningococcal b, unspecified |
Meningococcal b, unspecified formulation |
| 103 |
Meningococcal c conjugate |
Meningococcal c conjugate vaccine |
| 148 |
Meningococcal c/y-hib prp |
Meningococcal groups c and y and haemophilus b tetanus toxoid conjugate vaccine |
| 203 |
Meningococcal conjugate quadrivalent, menacwy-tt (mcv4) |
Meningococcal polysaccharide (groups a, c, y, w-135) tetanus toxoid conjugate vaccine 0.5ml dose, preservative free |
| 147 |
Meningococcal mcv4, unspecified formulation |
Meningococcal, mcv4, unspecified conjugate formulation(groups a, c, y and w-135) |
| 136 |
Meningococcal mcv4o |
Meningococcal oligosaccharide (groups a, c, y and w-135) diphtheria toxoid conjugate vaccine (mcv4o) |
| 114 |
Meningococcal mcv4p |
Meningococcal polysaccharide (groups a, c, y and w-135) diphtheria toxoid conjugate vaccine (mcv4p) |
| 32 |
Meningococcal mpsv4 |
Meningococcal polysaccharide vaccine (mpsv4) |
| 316 |
Meningococcal polysaccharide (menacwy-tt conjugate), (menb), pf |
Meningococcal polysaccharide (groups a, c, y, w) tetanus toxoid conjugate, meningococcal b recombinant vaccine, 0.5ml, preservative free |
| 167 |
Meningococcal, unknown serogroups |
Meningococcal vaccine of unknown formulation and unknown serogroups |
| 03 |
Mmr |
Measles, mumps and rubella virus vaccine |
| 94 |
Mmrv |
Measles, mumps, rubella, and varicella virus vaccine |
| 07 |
Mumps |
Mumps virus vaccine |
| 998 |
No vaccine administered |
No vaccine administered |
| 127 |
Novel influenza-h1n1-09 |
Novel influenza-h1n1-09, injectable |
| 128 |
Novel influenza-h1n1-09, all formulations |
Novel influenza-h1n1-09, all formulations |
| 125 |
Novel influenza-h1n1-09, nasal |
Novel influenza-h1n1-09, live virus for nasal administration |
| 126 |
Novel influenza-h1n1-09, preservative-free |
Novel influenza-h1n1-09, preservative-free, injectable |
| 02 |
Opv |
Trivalent poliovirus vaccine, live, oral |
| 179 |
Opv ,monovalent, unspecified |
Non-us monovalent oral polio vaccine, unspecified formulation |
| 178 |
Opv bivalent |
Non-us bivalent oral polio vaccine (types 1 and 3) |
| 182 |
Opv, unspecified |
Oral polio vaccine, unspecified formulation |
| 69 |
Parainfluenza-3 |
Parainfluenza-3 virus vaccine |
| 177 |
Pcv10 |
Pneumococcal conjugate vaccine, 10 valent |
| 11 |
Pertussis |
Pertussis vaccine |
| 23 |
Plague |
Plague vaccine |
| 133 |
Pneumococcal conjugate pcv 13 |
Pneumococcal conjugate vaccine, 13 valent |
| 100 |
Pneumococcal conjugate pcv 7 |
Pneumococcal conjugate vaccine, 7 valent |
| 215 |
Pneumococcal conjugate pcv15, polysaccharide crm197 conjugate, adjuvant, pf |
Pneumococcal conjugate vaccine 15-valent (pcv15), polysaccharide crm197 conjugate, adjuvant, preservative free |
| 216 |
Pneumococcal conjugate pcv20, polysaccharide crm197 conjugate, adjuvant, pf |
Pneumococcal conjugate vaccine 20-valent (pcv20), polysaccharide crm197 conjugate, adjuvant, preservative free |
| 327 |
Pneumococcal conjugate pcv21, polysaccharide crm197 conjugate, pf |
Pneumococcal conjugate vaccine, 21 valent (pcv21), polysaccharide crm197 conjugate, preservative free |
| 152 |
Pneumococcal conjugate, unspecified formulation |
Pneumococcal conjugate, unspecified formulation |
| 33 |
Pneumococcal polysaccharide ppv23 |
Pneumococcal polysaccharide vaccine, 23 valent |
| 109 |
Pneumococcal, unspecified formulation |
Pneumococcal vaccine, unspecified formulation |
| 89 |
Polio, unspecified formulation |
Poliovirus vaccine, unspecified formulation |
| 324 |
Poliovirus, inactivated, fractional-dose (fipv) |
Poliovirus, inactivated, fractional-dose (fipv) |
| 70 |
Q fever |
Q fever vaccine |
| 175 |
Rabies - im diploid cell culture |
Human rabies vaccine from human diploid cell culture |
| 176 |
Rabies - im fibroblast culture |
Human rabies vaccine from chicken fibroblast culture |
| 40 |
Rabies, intradermal injection |
Rabies vaccine, for intradermal injection |
| 18 |
Rabies, intramuscular injection |
Rabies vaccine, for intramuscular injection retired code |
| 90 |
Rabies, unspecified formulation |
Rabies vaccine, unspecified formulation |
| 99 |
Reserved - do not use |
Reserved - do not use |
| 315 |
Respiratory syncytial virus (rsv) mab, unspecified |
Respiratory syncytial virus (rsv) monoclonal antibody (mab), unspecified |
| 314 |
Respiratory syncytial virus (rsv) vaccine, unspecified |
Respiratory syncytial virus (rsv) vaccine, unspecified |
| 304 |
Respiratory syncytial virus (rsv), unspecified |
Respiratory syncytial virus (rsv), unspecified |
| 72 |
Rheumatic fever |
Rheumatic fever vaccine |
| 159 |
Rho(d) - unspecified formulation |
Rho(d) unspecified formulation |
| 157 |
Rho(d) -ig im |
Rho(d) immune globulin - im |
| 156 |
Rho(d)-ig |
Rho(d) immune globulin- iv or im |
| 73 |
Rift valley fever |
Rift valley fever vaccine |
| 34 |
Rig |
Rabies immune globulin |
| 119 |
Rotavirus, monovalent |
Rotavirus, live, monovalent vaccine |
| 116 |
Rotavirus, pentavalent |
Rotavirus, live, pentavalent vaccine |
| 74 |
Rotavirus, tetravalent |
Rotavirus, live, tetravalent vaccine |
| 122 |
Rotavirus, unspecified formulation |
Rotavirus vaccine, unspecified formulation |
| 305 |
Rsv, bivalent, protein subunit rsvpref, diluent reconstituted, 0.5 ml, pf |
Respiratory syncytial virus (rsv), vaccine, bivalent, protein subunit rsv prefusion f, diluent reconstituted, 0.5 ml, preservative free |
| 306 |
Rsv, mab, nirsevimab-alip, 0.5 ml, neonate to 24 months |
Respiratory syncytial virus (rsv) monoclonal antibody, igg1κ , (nirsevimab-alip), 0.5 ml, neonates and children to 24 months |
| 307 |
Rsv, mab, nirsevimab-alip, 1 ml, neonate to 24 months |
Respiratory syncytial virus (rsv) monoclonal antibody, igg1κ , (nirsevimab-alip), 1 ml, neonates and children to 24 months |
| 326 |
Rsv, mrna, injectable, pf |
Respiratory syncytial virus (rsv), mrna, injectable, preservative free |
| 303 |
Rsv, recombinant, protein subunit rsvpref, adjuvant reconstituted, 0.5 ml, pf |
Respiratory syncytial virus (rsv), vaccine, recombinant, protein subunit rsv prefusion f, adjuvant reconstituted, 0.5 ml, preservative free |
| 71 |
Rsv-igiv |
Respiratory syncytial virus immune globulin, intravenous |
| 93 |
Rsv-mab |
Respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 145 |
Rsv-mab (new) |
Respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
| 06 |
Rubella |
Rubella virus vaccine |
| 38 |
Rubella/mumps |
Rubella and mumps virus vaccine |
| 213 |
Sars-cov-2 (covid-19) vaccine, unspecified |
Sars-cov-2 (covid-19) vaccine, unspecified |
| 514 |
Sars-cov-2 covid-19 dna non-us vaccine (zydus cadila, zycov-d) |
Sars-cov-2 covid-19 dna non-us vaccine product (zydus cadila, zycov-d) |
| 513 |
Sars-cov-2 covid-19 ps non-us vaccine (anhui zhifei longcom, zifivax) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (anhui zhifei longcom, zifivax) |
| 517 |
Sars-cov-2 covid-19 ps non-us vaccine (biological e limited, corbevax) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (biological e limited, corbevax) |
| 515 |
Sars-cov-2 covid-19 ps non-us vaccine (medigen, mvc-cov1901) |
Sars-cov-2 covid-19 protein subunit non-us vaccine product (medigen, mvc-cov1901) |
| 512 |
Sars-cov-2 covid-19 vlp non-us vaccine (medicago, covifenz) |
Sars-cov-2 covid-19 virus like particle (vlp) non-us vaccine product (medicago, covifenz) |
| 76 |
Staphylococcus bacterio lysate |
Staphylococcus bacteriophage lysate |
| 138 |
Td (adult) |
Tetanus and diphtheria toxoids, not adsorbed, for adult use |
| 09 |
Td (adult), 2 lf tetanus toxoid, preservative free, adsorbed |
Tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 lf of tetanus toxoid and 2 lf of diphtheria toxoid) |
| 113 |
Td (adult), 5 lf tetanus toxoid, preservative free, adsorbed |
Tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 lf of tetanus toxoid and 2 lf of diphtheria toxoid) |
| 139 |
Td(adult) unspecified formulation |
Td(adult) unspecified formulation |
| 196 |
Td, adsorbed, preservative free, adult use, lf unspecified |
Tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, lf unspecified |
| 115 |
Tdap |
Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 180 |
Tetanus immune globulin |
Tetanus immune globulin |
| 35 |
Tetanus toxoid, adsorbed |
Tetanus toxoid, adsorbed |
| 142 |
Tetanus toxoid, not adsorbed |
Tetanus toxoid, not adsorbed |
| 112 |
Tetanus toxoid, unspecified formulation |
Tetanus toxoid, unspecified formulation |
| 77 |
Tick-borne encephalitis vaccine (non-us) |
Tick-borne encephalitis vaccine (non-us) |
| 223 |
Tick-borne encephalitis, inactivated, pf, 0.25ml |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25ml dose |
| 224 |
Tick-borne encephalitis, inactivated, pf, 0.5ml |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5ml dose |
| 222 |
Tick-borne encephalitis, unspecified |
Tick-borne encephalitis vaccine, unspecified |
| 13 |
Tig |
Tetanus immune globulin |
| 98 |
Tst, unspecified formulation |
Tuberculin skin test; unspecified formulation |
| 95 |
Tst-ot tine test |
Tuberculin skin test; old tuberculin, multipuncture device |
| 96 |
Tst-ppd intradermal |
Tuberculin skin test; purified protein derivative solution, intradermal |
| 97 |
Tst-ppd tine test |
Tuberculin skin test; purified protein derivative, multipuncture device |
| 78 |
Tularemia vaccine |
Tularemia vaccine |
| 190 |
Typhoid conjugate vaccine (tcv) |
Typhoid conjugate vaccine (non-us) |
| 25 |
Typhoid, oral |
Typhoid vaccine, live, oral |
| 41 |
Typhoid, parenteral |
Typhoid vaccine, parenteral, other than acetone-killed, dried |
| 53 |
Typhoid, parenteral, akd (u.s. military) |
Typhoid vaccine, parenteral, acetone-killed, dried (u.s. military) |
| 91 |
Typhoid, unspecified formulation |
Typhoid vaccine, unspecified formulation |
| 101 |
Typhoid, vicps |
Typhoid vi capsular polysaccharide vaccine |
| 131 |
Typhus, historical |
Historical record of a typhus vaccination |
| 999 |
Unknown |
Unknown vaccine or immune globulin |
| 75 |
Vaccinia (smallpox) |
Vaccinia (smallpox) vaccine |
| 105 |
Vaccinia (smallpox) diluted |
Vaccinia (smallpox) vaccine, diluted |
| 79 |
Vaccinia immune globulin |
Vaccinia immune globulin |
| 206 |
Vaccinia, smallpox mpox vaccine live, pf, sq or id injection |
Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
| 21 |
Varicella |
Varicella virus vaccine |
| 81 |
Vee, inactivated |
Venezuelan equine encephalitis, inactivated |
| 80 |
Vee, live |
Venezuelan equine encephalitis, live, attenuated |
| 92 |
Vee, unspecified formulation |
Venezuelan equine encephalitis vaccine, unspecified formulation |
| 36 |
Vzig |
Varicella zoster immune globulin |
| 117 |
Vzig (ind) |
Varicella zoster immune globulin (investigational new drug) |
| 37 |
Yellow fever live |
Yellow fever vaccine live |
| 183 |
Yellow fever vaccine live - alt |
Yellow fever vaccine live - alternative formulation for vaccine shortage |
| 184 |
Yellow fever, unspecified |
Yellow fever vaccine, unspecified formulation |
| 121 |
Zoster live |
Zoster vaccine, live |
| 187 |
Zoster recombinant |
Zoster vaccine recombinant |
| 188 |
Zoster, unspecified formulation |
Zoster vaccine, unspecified formulation |
iEHR
